pg_0001

Medical data is for informational purposes only. You should always consult your family physician, or one of our referral physicians prior to treatment.

Anti-amoebic Treatment for

Rheumatoid Disease

Gus J. Prosch, Jr.

(The Institute of Biomolecular Medicine: Gus J. Prosch, Jr., 1985;

Formerly published in The Journal of the Rheumatoid Disease

Foundation, Volume 1, Number 1,

The Arthritis Trust of America

7376 Walker Road, Fairview, Tn 37062

Introduction

Good morning, to all you visitors, friends and supporters of

The Rheumatoid Disease Foundation. I’m honored to have been

asked by The Rheumatoid Disease Foundation to speak to you and

share with you some of the exciting new developments and advances

that ar e being made concerning the treatment of Rheumatoid Arthritis

and other Rheumatoid Diseases. I would like to personally thank

each and every one of you who have supported The Rheumatoid

Disease Foundation and want you to know that if it had not been for

the personal help and financial support of many of you and thou-

sands of other supporters across the entire United States, our progress

would have been very minimal, but thanks to you and all our sup-

porters, our knowledge and research is moving and progressing at a

very rapid rate.

I was asked to speak on the anti-amoebic treatment of Rheuma-

toid Disease and this is a very broad subject. I know that there are

some people here who are not familiar with our work so I will give

a rapid background review of our work, what has been done, and

then go into the actual treatments and support methods being recom-

mended at the present time.

Brief History of Development

of this Treatment in the United States

As a physician, I have over the years specialized in treating

overweight problems, and I’ve had an intense interest in seeking

means to treat Rheumatoid Arthritis and other chronic degenerative

diseases. Work done by Dr. Jack M. Blount, Jr., of Philadelphia MS,

came to my attention about three years ago. Although I was very

skeptical, my subsequent interviews with several of Dr. Blount’s

successfully treated arthritic patients made me curious enough to

seek out and review the medical literature on advances and treatment

of Rheumatoid Diseases. What I found convinced me that Dr. Blount’s

theory and treatment mode made a good deal of sense.

The treatment advocated by Dr. Blount was based primarily on

the published research of Professor Roger Wyburn-Mason of En-

gland. Dr. Blount, a victim of Rheumatoid Arthritis, had by early

1974 been nearly totally disabled. He had undergone replacement of

his right hip joint, but the pain and disability had gotten worse. All

the usual treatments had failed to alleviate his pain or slow the progress

of his disease. In early 1976, Dr. Blount read an article in Modern

Medicine entitled “Has One man Found the Cause and Cure of Rheu-

matoid Disease.” According to that article, Dr. Wyburn-Mason claimed

that Rheumatoid Arthritis is caused by a germ, a protozoan, not

unlike the lettuce bug amoebae.

Dr. Blount decided to try Wyburn-Mason’s treatment, but the

suggested drug, Clotrimazole, was not available in the U.S. How-

ever, investigation led him to compare Clotrimazole with another

drug called Flagyl (produced by G.D. Searle and Co.), and known

generically as Metronidazole. He found the two drugs to be nearly

identical. The American drug has been used since 1962 to treat

Amebiasis and Tricomonas Vaginitis.

Dr. Blount knew the standard dosage for treating Amebiasis or

Trichomonas would not be strong enough since it would have been

noticed by other researchers to relieve Arthritis if the drug was effec-

tive as Dr. Wyburn-Mason suggested. Dr. Blount increased the

dosage and during the next two weeks he found the soreness, stiff-

ness and s welling in his joints started going away. Repeating the

course of treatment every two weeks, he found his condition was

improving. After treating himself for three months, he asked several

of his former patients if they would be interested in trying the treat-

ment for their arthritic conditions. Some 30 patients received the

treatment during the summer of 1977. Most of them had the same

good experience as Dr. Blount. Since that time, Dr. Blount has

treated over 16,000 patients [eventually 17,000: Ed.], most of whom

have been significantly relieved.

After learning about Dr. Blount’s work, I spent several months

thoroughly investigating this theory in order to determine if there

was any truth or substance to his claims. I took the following steps

to thoroughly check out and investigate his work.

1. I reviewed the available but scanty literature in the medical

library and concluded that not only was the theory of a type of germ

causing Rheumatoid Arthritis possible but it was probable.

2. I then sent several Rheumatoid Arthritis patients to Dr. Blount

to be treated and was quite impressed with their results.

3. I then visited Dr. Blount to study the theory and treatment in

more detail. I was tremendously impressed with his knowledge, his

sincerity and his dedication. He willingly shared everything he knew

with me and offered to help me in any way possible. I learned from

him that his work and treatment was based on previous research by

Dr. Roger Wyburn-Mason in London, England, who claimed that

the cause of Rheumatoid Arthritis and other auto-immune or col-

lagen diseases was due to a certain pathogenic, free-living amoebae

of which every living person is infected to some degree. I learned

that Dr. Wyburn-Mason’s credentials and background were impec-

cable and of the highest caliber and obviously he was of genius

status. He was a protozoologist, a pharmacologist and rheumatolo-

gist and had researched this amoeba theory for 26 years. He had

published numerous articles in the medical literature as well as writ-

ing several books about his work.

4. I then contacted Dr. Roger Wyburn-Mason and made ar-

rangements to get a copy of his book entitled The Causation of

Rheumatoid Disease and Many Human Cancers — A New Concept

in Medicine. I studied this book in detail.

5. I spent hundreds of hours in the medical library studying

Gus J. Prosch, Jr., M.D.